Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 30 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Divyaanka I.

Singapore

USD 30 /hr

Freelance scientific writer with research experience in oncology, metabolic diseases and bacteriology

Profile Summary

I am a published researcher with 10 + years of experience in the field of oncology, metabolic & infectious diseases. I have knowledge of clinical trials and lead molecules in oncology and have developed an anti-cancer molecule for which I have a patent. My passion for science is tied to communication and I can effectively translate scientific data and concepts to the written word. My writing experience includes research articles, book chapter, reviews and research grants. I understand the requirements of each of these formats and can deliver content to high standards of scientific accuracy and readability. I have also successfully extended my editorial and written expertise beyond academics to editing business case studies and generating sponsorship proposals to government bodies and private companies. I look forward to exciting work in my area of expertise and delivering high quality within acceptable timelines.

Subject Matter Expertise

• ★ Oncology
• ★ Infectious Disease
• ★ Metabolism & Metabolic Disease
• ☆ Biochemistry
• ☆ Oxidative Stress & Mitochondrial Function
• ☆ Molecular Biology
• ☆ Cell Signaling Pathways
• ☆ Inflammation

Services

• Writing

Writing Clinical Trial Documentation, Technical Writing

Work Experience

Postdoctoral Research Fellow

Duke-NUS Medical School

April 2019 - September 2019

CSIR Nehru Postdoctoral Research Fellow

CISR- Institute of Genomics and Integrative Biology

May 2016 - June 2018

Research Associate

Indian institute of science

July 2014 - November 2014

Education

PhD

Indian Institute of Science

August 2007 - January 2014

MSC Genetics

Osmania University

May 2005 - May 2007

BSC Microbiology, Biochemistry, Chemistry

St Francis College for Women, Osmania University

April 2002 - April 2005

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2017). Mitochondrial Function in Allergic Disease . Current allergy and asthma reports.

(2017). Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction . Biochemical pharmacology.

(2016). A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis . Biochemical pharmacology.

(2016). Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain . The FEBS journal.

PATENT

(2017). Novel Inhibitors of Antiapoptotic BCL-2 protein .

BOOK CHAPTER

Targeted Cancer Therapy: The Role of BCL2 Inhibitors . Biotechnology Volume-7 (Drug Discovery).